

Integris Medtech IPO GMP
Integris Medtech IPO is a Mainboard issue. It opens on 27 Nov 2026 and closes on 1 Dec 2026. Listing is expected on 4 Dec 2026.
GMP trend
No GMP has been recorded for this IPO yet.
IPO details
- Min. investment
- Not published
- Fresh issue
- ₹600 Cr
- Offer for sale
- 1.08 Cr shares
- Face value
- ₹1 per share
- Sector
- Medical Equipment & Supplies
- QIB quota
- Not less than 75% of the Offer
- NII quota
- Not more than 15% of the Offer
- Retail quota
- Not more than 10% of the Offer
- Promoter holding
- 83.24%
- Listing at
- NSE, BSE
- Registrar
- Kfin Technologies Ltd.
- Lead managers
- ICICI Securities Ltd., Citigroup Global Markets India Pvt.Ltd., IIFL Capital Services Ltd., Axial Capital Pvt.Ltd.
Timeline
- Anchor bidding
- 26 Nov 2026
- Open date
- 27 Nov 2026
- Close date
- 1 Dec 2026
- Allotment
- 2 Dec 2026
- Refunds start
- 3 Dec 2026
- Shares in demat
- 3 Dec 2026
- Listing date
- 4 Dec 2026
- Anchor lock-in ends (50%)
- 1 Jan 2027
- Anchor lock-in ends (rest)
- 2 Mar 2027
Subscription status
Bidding opens 27 Nov 2026.
Financials (₹ Cr)
| Period ended | 30-Jun-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
|---|---|---|---|---|
| Assets | 4,019.62 | 3,641.34 | 2,989.2 | 2,553.87 |
| Revenue | 508.93 | 1,959.58 | 1,582.26 | 1,369.66 |
| Profit After Tax | 267.57 | 70.68 | 4.88 | 40.54 |
| Net Worth | 3,889.99 | 2,752.52 | 2,681.02 | 2,629.52 |
| Reserves & Surplus | 2,299.84 | 1,150.74 | 1,135.71 | 1,073.12 |
| Total Borrowing | 793.42 | 1,729.46 | 813.1 | 556.54 |
Objects of the issue
- Repayment/ prepayment, in full or in part, of certain outstanding borrowings, interest accrued and prepayment penalties, as applicable, availed by:
- The wholly-owned Subsidiaries, namely, Translumina Therapeutics Pvt.Ltd. (Translumina Therapeutics), Transhealth Pvt.Ltd. (Transhealth) ) and HaleMed Medical Pvt.Ltd.
- The step-down Subsidiaries, namely, CPC Diagnostics Pvt.Ltd., Chemopharm Sdn. Bhd., Chemoscience Pte Ltd., Lifeline Diagnostics Supplies Inc., Hausen Bernstein Co. Ltd, Medigene Sdn. Bhd., Research Instruments Sdn Bhd and Research Instruments Pte. Ltd.
- General Corporate Purposes
Promoters
Evercure Holdings Pte.Ltd., Medicore Holdings Pte.Ltd., Gurmit Singh Chugh, Punita Sharma
About Integris Medtech
Founded in 2008, Integris Medtech Ltd is an India based international company which manufactures and provides global medical products and laboratory solutions for medical products and laboratory solutions. The company designs, manufactures, markets, and distributes an extensive range of medical devices and solutions that include cardiovascular devices, clinical diagnostics, and scientific laboratory solutions. Integris Medtech has operations located in India, Germany, and the Netherlands. It sells its product line in more than 65 international markets in India, Europe, and Southeast Asia. The company's customer segment comprises of more than 9,500 laboratories and 2,000 hospitals and cathlabs and a portfolio of over 22,000 SKUs with more than 200 brands of laboratory and cardiovascular segments. The core divisions of the company's operations include: Cardiovascular Devices – including drug eluting stents, drug coated balloons, advanced coronary interventions and vascular access. Laboratory Solutions – including clinical, research, and industrial laboratory devices, reagents, and consumables, as well as instrumentation service such as installation, maintenance and calibration via its BioCal product line. The firm caters to laboratories and hospital facilities situated in India, Singapore, Thailand, Malaysia, and the Philippines, serving the government sector as well as private sector entities. European operations of the company deal mostly with products used in cardiology, which include its own product range, namely the Chrome and Protégé series of instruments. By June 30, 2025, Integris Medtech boasted 1,879 employees, which were sales, service, and application experts. Moreover, more than 15,000 patients were supported by the company through more than 100 clinical trial sites in various parts of the world.
Company contact
- Name
- Integris Medtech
- Phone
- +91 120 4531422
- Website
- www.integrismedtech.com
- Address
- 1 st Floor, Metro Tower LSC, M.O.R Land, New Rajinder Nagar, North Delhi, New Delhi, 110060
Registrar contact
- Name
- Kfin Technologies Ltd.
- Phone
- 040-79615565
- Website
- ipostatus.kfintech.com
Integris Medtech IPO: FAQs
2 questions
01When is the Integris Medtech IPO allotment date?
The basis of allotment is expected on 2 Dec 2026. Kfin Technologies Ltd. is the registrar, where you can check allotment status with your PAN or application number.
02When will Integris Medtech shares list?
The tentative listing date is 4 Dec 2026 on NSE and BSE.






